SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
This Quarter Return
+13.67%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$871M
AUM Growth
+$871M
(+50%)
Cap. Flow
+$211M
Cap. Flow
% of AUM
24.21%
Top 10 Holdings %
Top 10 Hldgs %
66.75%
Holding
73
New
20
Increased
22
Reduced
4
Closed
14
Top Buys
| 1 |
Iterum Therapeutics
ITRM
|
$18.8M |
| 2 |
AGN
Allergan plc
AGN
|
$17M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$16.3M |
| 4 |
Kiniksa Pharmaceuticals
KNSA
|
$16M |
| 5 |
CELG
Celgene Corp
CELG
|
$14.6M |
Top Sells
| 1 |
NCNA
NuCana
NCNA
|
$76M |
| 2 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$17.1M |
| 3 |
Apellis Pharmaceuticals
APLS
|
$6.51M |
| 4 |
ATYR
aTyr Pharma
ATYR
|
$4.95M |
| 5 |
Bristol-Myers Squibb
BMY
|
$951K |
Sector Composition
| 1 | Healthcare | 82.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ascendis Pharma
ASND
$11.8B
| $165M | 18.69% | 2,479,514 | – | – |
|
|
OBSV
2
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $71.9M | 8.15% | 4,749,623 | – | – |
|
3
Natera
NTRA
$23.1B
| $58.4M | 6.61% | 3,100,560 | – | – |
|
4
Merus
MRUS
$4.98B
| $44.6M | 5.06% | 1,961,039 | – | – |
|
5
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $40.5M | 4.59% | 2,893,221 | – | – |
|
|
ONCE
6
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $39.8M | 4.51% | 481,270 | – | – |
|
|
BOLD
7
DELISTED
Audentes Therapeutics, Inc
BOLD
| $35.7M | 4.04% | 933,640 -446,663 | -32% | -$17.1M |
|
8
Aclaris Therapeutics
ACRS
$209M
| $30.7M | 3.48% | 1,539,480 | – | – |
|
|
9
Iterum Therapeutics
ITRM
$30.2M
| $18.8M | 2.13% | +1,726,514 | New | +$18.8M |
|
|
AGN
10
DELISTED
Allergan plc
AGN
| $18.6M | 2.11% | 111,550 +102,171 | +1,089% | +$17M |
|
|
ALXN
11
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $17.5M | 1.98% | 140,752 +131,626 | +1,442% | +$16.3M |
|
|
12
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $16M | 1.81% | +922,700 | New | +$16M |
|
|
CELG
13
DELISTED
Celgene Corp
CELG
| $14.6M | 1.66% | +184,399 | New | +$14.6M |
|
|
14
Apellis Pharmaceuticals
APLS
$3.48B
| $13.5M | 1.53% | 615,802 -295,950 | -32% | -$6.51M |
|
|
NCNA
15
NuCana
NCNA
$6.09M
| $12.7M | 1.44% | 666,666 -4,000,000 | -86% | -$76M |
|
16
AstraZeneca
AZN
$248B
| $11.6M | 1.31% | 329,800 +307,968 | +1,411% | +$10.8M |
|
|
AMRN
17
Amarin Corp
AMRN
$311M
| $10.3M | 1.16% | 3,321,588 | – | – |
|
|
AIMT
18
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $10.1M | 1.14% | 375,044 +354,736 | +1,747% | +$9.54M |
|
19
Heron Therapeutics
HRTX
$207M
| $10M | 1.14% | 258,585 +228,452 | +758% | +$8.88M |
|
|
ICPT
20
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $8.96M | 1.02% | +106,817 | New | +$8.96M |
|
|
GWPH
21
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $8.8M | 1% | 63,070 +59,433 | +1,634% | +$8.29M |
|
|
BLUE
22
DELISTED
bluebird bio
BLUE
| $8.69M | 0.98% | +55,371 | New | +$8.69M |
|
|
ADMS
23
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $7.32M | 0.83% | 283,398 +267,192 | +1,649% | +$6.9M |
|
24
Rigel Pharmaceuticals
RIGL
$697M
| $6.43M | 0.73% | 2,272,727 +2,169,753 | +2,107% | +$6.14M |
|
25
Sarepta Therapeutics
SRPT
$1.78B
| $6.4M | 0.72% | +48,400 | New | +$6.4M |
|